Clinical trial
HEAD-Study Optimizing the Treatment of Children With BECTS
NCT00471744 · Ludwig-Maximilians - University of Munich, Other · Terminated
Key facts
| NCT number | NCT00471744 |
|---|---|
| Title | HEAD-Study Optimizing the Treatment of Children With BECTS |
| Official title | HEAD-TO-HEAD Evaluation of the Antiepileptic Drugs Levetiracetam (LEV) vs. Sulthiame (STM) in a German Multi-Centre, Doubleblind Controlled Trial in Children With Benign Epilepsy With Centro-Temporal Spikes |
| Acronym | HEAD |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Rolandic |
| Intervention type | Drug |
| Interventions | Treatment with levetiracetam or sulthiame over a six-month period. |
| Enrollment | 44 |
| Start date | Jun 1, 2006 |
| Completion | Jul 1, 2008 |
| First posted | May 10, 2007 |
| Last update posted | Jan 29, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: